Tamoxifen and the Farnesyl Transferase Inhibitor FTI-277 Synergize to Inhibit Growth in Estrogen Receptor-Positive Breast Tumor Cell Lines-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tamoxifen and the Farnesyl Transferase Inhibitor FTI-277 Synergize to Inhibit Growth in Estrogen Receptor-Positive Breast Tumor Cell Lines

Published:2003-03 Issue:1 Volume:78 Page:59-67
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Ellis Chad A.,Vos Michele D.,Wickline Meredith,Riley Christine,Vallecorsa Teresa,Telford William G.,Zujewski JoAnne,Clark Geoffrey J.

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.springerlink.com/index/pdf/10.1023/A:1022105511409

Reference52 articles.

1. Bos JL: Ras oncogenes in human cancer: a review. Cancer Res 49: 4682-4689, 1989

2. Clark GJ, Der CJ: Oncogenic activation of Ras proteins. In: Dickey BF, Birnbaumer L (eds) GTPases in Biology. Springer-Verlag, Berlin, 1993, pp. 259-287

3. Shirasawa S, Furuse M, Yokoyama N, Sasazuki T: Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science 260: 85-88, 1993

4. Plattner R, Anderson MJ, Sato KY, Fasching CL, Der CJ, Stanbridge EJ: Loss of oncogenic ras expression does not correlate with loss of tumorigenicity in human cells. Proc Natl Acad Sci USA 93: 6665-6670, 1996

5. Miyakis S, Sourvinos G, Spandidos DA: Differential expression and mutation of the ras family genes in human breast cancer. Biochem Biophys Res Commun 251: 609-612, 1998

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Farnesyltransferase Inhibitors: A Comprehensive Review Based on Quantitative Structural Analysis;Current Medicinal Chemistry;2013-11

2. Ras Activation Induces Expression of Raet1 Family NK Receptor Ligands;The Journal of Immunology;2012-07-13

3. Hormone-Biological Therapy in Breast Cancer: Preclinical Evidence,Clinical Studies and Future Directions;Current Cancer Drug Targets;2010-02-01

4. Therapeutic Potential of New 4-hydroxy-tamoxifen-Loaded pH-gradient Liposomes in a Multiple Myeloma Experimental Model;Pharmaceutical Research;2009-12-23

5. Recent advances in systemic therapy. When HER2 is not the target: advances in the treatment of HER2-negative metastatic breast cancer;Breast Cancer Research;2009-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3